Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Côte D'Ivoire

AIDS ◽  
2004 ◽  
Vol 18 (3) ◽  
pp. 413-419 ◽  
Author(s):  
Stéphania Koblavi-Dème ◽  
Luc Kestens ◽  
Debra Hanson ◽  
Ronald A Otten ◽  
Marie-Yolande Borget ◽  
...  
Keyword(s):  
Viral Load ◽  
Cote D'ivoire ◽  
Immune Activation ◽  
Plasma Viral Load ◽  
Côte D’Ivoire ◽  
Cote D’Ivoire ◽  
Côte D'ivoire ◽  
Hiv 1

scholarly journals Adaptation of an electronic dashboard to monitor HIV viral load testing in Côte d’Ivoire

2021 ◽  
Vol 10 (1) ◽  
Author(s):  
Mary Kirk ◽  
Paul H. Assoa ◽  
Casey Iiams-Hauser ◽  
Yves-Rolland Kouabenan ◽  
Jennifer Antilla ◽  
...  
Keyword(s):  
Viral Load ◽  
Information Systems ◽  
Cote D'ivoire ◽  
Côte D’Ivoire ◽  
Load Testing ◽  
Hiv Viral Load ◽  
Cote D’Ivoire ◽  
Côte D'ivoire ◽  
Nations Programme ◽  
United Nations Programme

Background: The Ministère de le Santé et de l’Hygiène Publique in Côte d’Ivoire and the international community have invested in health information systems in Côte d’Ivoire since 2009, including electronic laboratory information systems. These systems have been implemented in more than 80 laboratories to date and capture all test results produced from these laboratories, including HIV viral load (VL) testing. In 2018 the national HIV programme in Côte d’Ivoire requested international support to develop real-time tools such as dashboards to aggregate and display test-specific data such as HIV VL testing to support the country’s programmatic response to HIV.Intervention: The VL dashboard was adapted in 2018 using source software code obtained from the Kenyan Ministry of Health and modified for the Ivorian context. The dashboard enables users to assess relevant clinical data from all Ivoirians living with HIV who undergo VL testing through dashboard data visualisations, including the number of VL tests, kinds of samples tested, and VL levels stratified by demographics and geographic location.Lessons learnt: The VL dashboard enables rapid analysis of VL testing data from across the country and enables the national HIV programme, donors and partners to respond rapidly to issues pertaining to access, turn-around times and others.Recommendations: Adapting existing open-source software is an effective and efficient way to implement transformative tools such as dashboards. The VL dashboard will likely be an essential tool for Côte d’Ivoire to meet the United Nations Programme on HIV/AIDS 90-90-90 targets.

Distribution of HIV-1 Subtypes Among HIV-Seropositive Patients in the Interior of Côte d'Ivoire

2000 ◽  
Vol 23 (5) ◽  
pp. 430-436 ◽  
Author(s):  
John N. Nkengasong ◽  
Chi-Cheng Luo ◽  
Lucien Abouya ◽  
Danuta Pieniazek ◽  
Chantal Maurice ◽  
...  
Keyword(s):  
Cote D'ivoire ◽  
Côte D’Ivoire ◽  
Cote D’Ivoire ◽  
Côte D'ivoire ◽  
Hiv Seropositive ◽  
Hiv 1

Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'Ivoire

AIDS ◽  
2004 ◽  
Vol 18 (14) ◽  
pp. 1905-1913 ◽  
Author(s):  
Patricia Fassinou ◽  
Narcisse Elenga ◽  
François Rouet ◽  
Rockiath Laguide ◽  
Kouakou A Kouakoussui ◽  
...  
Keyword(s):  
Cote D'ivoire ◽  
Côte D’Ivoire ◽  
Cote D’Ivoire ◽  
Highly Active ◽  
Antiretroviral Therapies ◽  
Côte D'ivoire ◽  
Hiv 1

Effect of methodology on detection of HIV-1/HIV-2 dual infections in Côte d'Ivoire

1994 ◽  
Vol 48 (1) ◽  
pp. 23-30 ◽  
Author(s):  
Martine Peeters ◽  
Katrien Fransen ◽  
Guy-Michel Gershy-Damet ◽  
Betty Willems ◽  
Konan Koffi ◽  
...  
Keyword(s):  
Cote D'ivoire ◽  
Côte D’Ivoire ◽  
Cote D’Ivoire ◽  
Côte D'ivoire ◽  
Hiv 1 ◽  
Dual Infections

scholarly journals Concentrations of Tenofovir and Emtricitabine in Breast Milk of HIV-1-Infected Women in Abidjan, Côte d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2

2010 ◽  
Vol 55 (3) ◽  
pp. 1315-1317 ◽  
Author(s):  
Sihem Benaboud ◽  
Alain Pruvost ◽  
Patrick A. Coffie ◽  
Didier K. Ekouévi ◽  
Saïk Urien ◽  
...  
Keyword(s):  
Breast Milk ◽  
Cote D'ivoire ◽  
Côte D’Ivoire ◽  
Inhibitory Concentration ◽  
Plasma Concentrations ◽  
Viral Resistance ◽  
Cote D’Ivoire ◽  
Côte D'ivoire ◽  
Hiv 1

ABSTRACTThe aim was to evaluate emtricitabine (FTC) and tenofovir (TFV) neonatal ingestion through breast milk. Median TFV and FTC breast milk doses represented 0.03% and 2%, respectively, of the proposed oral infant doses. Neonatal simulated plasma concentrations were extremely low for TFV but between the half-maximal inhibitory concentration and the adult minimal expected concentration for FTC. The rare children who will acquire HIV despite TDF-FTC therapy will need to be monitored for viral resistance acquisition.

Primary HIV-1 drug resistance in Abidjan (Côte d'Ivoire): a genotypic and phenotypic study

AIDS ◽  
2002 ◽  
Vol 16 (3) ◽  
pp. 488-491 ◽  
Author(s):  
Thomas d'Aquin Toni ◽  
Bernard Masquelier ◽  
Dominique Bonard ◽  
Muriel Faure ◽  
Charlotte Huët ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Cote D'ivoire ◽  
Côte D’Ivoire ◽  
Cote D’Ivoire ◽  
Côte D'ivoire ◽  
Hiv 1
Sign in / Sign up

Export Citation Format

Share Document